In our previous study, the humanized single-chain variable fragment (scFv) antibody against the CTGF C-terminal domain was obtained from a phage display human antibody library [11], and it was shown that it may play a potential role in attenuating pulmonary fibrosis in mice [12]. The gene discussed is CCN2; the disease is pulmonary fibrosis.